N-Methyl-alpha-phenylsuccinimide
N-Methyl-alpha-phenylsuccinimide Brand names, N-Methyl-alpha-phenylsuccinimide Analogs
- (+/-)-N-Methyl-2-phenylsuccinimide
- 1-Methyl-3-Phenylsuccinimide
- Epimid
- Fenosuccimide
- Fensuccimide [DCIT]
- Fensuximida [INN-Spanish]
- Lifene
- Methylphenylsuccinimide
- Milontin
- Milontin (TN)
- Milonton
- Mirontin
- Mirotin;7 Phenosuccimide
- N-Methyl-2-phenylsuccinimide
- N-Methyl-alpha-phenolsuccinimide
- N-Methyl-alpha-phenylsuccinimide
- Phensuximid
- Phensuximide (USP)
- Phensuximide [BAN:INN]
- Phensuximidum [INN-Latin]
- Phenylsuximide
- Succinimide, N-methyl-2-phenyl-
- Succitimal
N-Methyl-alpha-phenylsuccinimide Brand Names Mixture
- No information avaliable
N-Methyl-alpha-phenylsuccinimide Chemical_Formula
C11H11NO2
N-Methyl-alpha-phenylsuccinimide RX_link
No information avaliable
N-Methyl-alpha-phenylsuccinimide fda sheet
N-Methyl-alpha-phenylsuccinimide msds (material safety sheet)
N-Methyl-alpha-phenylsuccinimide Synthesis Reference
No information avaliable
N-Methyl-alpha-phenylsuccinimide Molecular Weight
189.211 g/mol
N-Methyl-alpha-phenylsuccinimide Melting Point
72 oC
N-Methyl-alpha-phenylsuccinimide H2O Solubility
7020 mg/L
N-Methyl-alpha-phenylsuccinimide State
Solid
N-Methyl-alpha-phenylsuccinimide LogP
1.079
N-Methyl-alpha-phenylsuccinimide Dosage Forms
Capsules
N-Methyl-alpha-phenylsuccinimide Indication
For the treatment of epilepsy
N-Methyl-alpha-phenylsuccinimide Pharmacology
Phensuximide suppresses the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of consciousness in absence (petit mal) seizures. The frequency of attacks is reduced by depression of nerve transmission in the motor cortex.
N-Methyl-alpha-phenylsuccinimide Absorption
Rapid and complete
N-Methyl-alpha-phenylsuccinimide side effects and Toxicity
No information avaliable
N-Methyl-alpha-phenylsuccinimide Patient Information
No information avaliable
N-Methyl-alpha-phenylsuccinimide Organisms Affected
Humans and other mammals
